GLP-1-Based Therapy for Diabetes: What You Do Not Know Can Hurt You

被引：51

作者：

Butler, Peter C. ^{[1
]}

Dry, Sarah

Elashoff, Robert

机构：

[1] Univ Calif Los Angeles, Dept Pathol, Larry L Hillblom Islet Res Ctr, Los Angeles, CA 90024 USA

来源：

DIABETES CARE | 2010年 / 33卷 / 02期

关键词：

BETA-CELL PROLIFERATION; MYOCARDIAL-INFARCTION; PANCREATITIS; EXENATIDE; RISK; SITAGLIPTIN; SYSTEM; TRIAL;

D O I：

10.2337/dc09-1902

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：453 / 455

页数：3

共 28 条

[1] [Anonymous], SIT MARK JAN JAN AC
[2] [Anonymous], REUTERS 0925
[3] Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
Buse, John B.
Rosenstock, Julio
Sesti, Giorgio
Schmidt, Wolfgang E.
Montanya, Eduard
Brett, Jason H.
Zychma, Marcin
Blonde, Lawrence
[J]. LANCET, 2009, 374 (9683) : 39 - 47
[4] GLP-1 receptor signaling:: effects on pancreatic β-cell proliferation and survival
Buteau, J.
[J]. DIABETES & METABOLISM, 2008, 34 : S73 - S77
[5] BUTLER AE, 2009, DIABETOLOGI IN PRESS
[6] Cure P, 2008, NEW ENGL J MED, V358, P1969, DOI 10.1056/NEJMc0707137
[7] The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
Currie, C. J.
Poole, C. D.
Gale, E. A. M.
[J]. DIABETOLOGIA, 2009, 52 (09) : 1766 - 1777
[8] Exenatide (Exendin-4)-induced pancreatitis - A case report
Denker, PS
Dimarco, PE
[J]. DIABETES CARE, 2006, 29 (02) : 471 - 471
[9] Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide
Dore, David D.
Seeger, John D.
Chan, K. Arnold
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (04) : 1019 - 1027
[10] Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial
Dormandy, JA
Charbonnel, B
Eckland, DJA
Erdmann, E
Massi-Benedetti, M
Kmoules, IK
Skene, AM
Tan, MH
Lefébvre, PJ
Murray, GD
Standl, E
Wilcox, RG
Wlhelmsen, L
Betteridge, J
Birkeland, K
Golay, A
Heine, RJ
Korányi, L
Laakso, M
Mokán, M
Norkus, A
Pirags, V
Podar, T
Scheen, A
Scherbaum, W
Schernthaner, G
Schmitz, O
Skrha, J
Smith, U
Taton, J
[J]. LANCET, 2005, 366 (9493) : 1279 - 1289

← 1 2 3 →